Search Results for: ADVANCED DELIVERY DEVICES New Drug
Articles
ADVANCED DELIVERY DEVICES - Getting It Right: The Importance of End-User Research in the Design of a New Drug Delivery System October 1, 2014
Chris Evans believes that designing a drug delivery system that will truly resonate with patients requires insight into the unique experiences of those users by conducting research that will drive innovation in the design and development process to create a solution that works in a variety of situations.
ADVANCED DELIVERY DEVICES - Wearable Bolus Injectors - A New Class of Patient-Friendly Drug Delivery Systems May 6, 2014
Michael D. Hooven, MSME, indicates bolus injectors represent one of the most exciting new opportunities in the field of medical devices, and his company’s focus on developing innovative technology in combination with an intense emphasis on Human Factors has resulted in a system that is unique in a number of ways.
ADVANCED DELIVERY DEVICES - New Drug Delivery & Stabilization Platforms Gaining Global Interest March 5, 2014
Sam de Costa, PhD, believes the launch of two stabilization and drug delivery platforms that have the potential to revolutionize the delivery of vaccines, therapeutics, and diagnostics, while significantly cutting costs, has attracted sharp interest from pharmaceutical and biotech companies around the world.
Amneal & Apiject to Expand Sterile & Blow-Fill-Seal Capabilities for Advanced Pharmaceutical Manufacturing in the US May 8, 2025
Amneal Pharmaceuticals, Inc. and Apiject Systems, Corp. recently announced a strategic collaboration to expand domestic production of Apiject’s BFS-based injectable...SPECIAL FEATURE - PFS & Parenteral Delivery: Innovation Is Focused on Patient-Centric, Smart & Sustainable Solutions May 7, 2025
Contributor Cindy H. Dubin speaks with several innovating companies to discuss trends in PFS as well as advancements in autoinjectors and innovations in parenteral delivery.
LEADERSHIP PANEL - What Will Have the Most Impact on Drug Development in 2025? February 11, 2025
Contributor Cindy H. Dubin asked several life science leaders what they believe will have the greatest impact on drug development in 2025.
FOCUSED ULTRASOUND - Overcoming Drug Delivery Challenges February 10, 2025
Neal F. Kassell, MD, says one promising approach, focused ultrasound (FUS), is emerging as a revolutionary tool, enabling non-invasive, targeted BBB disruption. This method holds transformative potential in delivering therapies for neurodegenerative diseases and other challenging conditions, setting the stage for novel treatments in the years ahead.
UPM Biomedicals Launches FibGel, World’s First Injectable Nanocellulose Hydrogel for Medical Devices October 24, 2024
UPM Biomedicals recently announced the launch of FibGel, a natural injectable hydrogel for permanent implantable medical devices. FibGel is a...EXECUTIVE INTERVIEW - Respiratory Drug Development: Lonza Experts Share Trends & Key Takeaways October 1, 2024
Beatriz Fernandes, Principal Scientist for R&D, and Kim Shepard, Director, Technology Head Respiratory Delivery, at Lonza, discuss their presentations at RDD 2024, current trends, and the future of the inhalation space.
Formulated Solutions Adds Third GMP Aerosol Line to Deliver Fill Flexibility, Accelerate Delivery Timelines & Increase Production Capacity September 18, 2024
Formulated Solutions has added a third GMP aerosol production line as it prepares for future customer demand. Featuring the latest...TekniPlex Healthcare to Highlight Concept-to-Commercialization Capabilities for Class III Implantable Devices & Delivery Systems September 17, 2024
TekniPlex Healthcare, which utilizes advanced materials science expertise to help deliver better patient outcomes, will emphasize its substantially expanded capabilities...Serán Bioscience Announces $200-Million Strategic Growth Transaction & Plans for New Commercial Facility September 17, 2024
Serán Bioscience recently announced a strategic growth transaction of more than $200 million. Bain Capital Life Sciences led the transaction,...SPECIAL FEATURE - Injection Devices: From Pens & Autoinjectors to Pills, Sprays & Capsules, Injections Become More Efficient September 6, 2024
Contributor Cindy H. Dubin reports on innovative and promising injection technologies that are ever more user friendly, versatile, precise, and life-saving.
2024 Analytical Testing eBook - Providers Offer Versatile, Advanced & Expanded Services August 16, 2024
Learn more about Stevanato Group and LGM Pharma in this exclusive Drug Development & Delivery annual Analytical Testing eBook.
2024 Respiratory Drug Development eBook – CDMOs Will Become More Essential to Inhalation Device Programs July 12, 2024
In this fifth annual Respiratory e-book, learn more about several companies and their contributions to inhalation drug delivery and device design.
SPECIAL FEATURE - Prefilled Syringes & Parenteral Delivery: Next-Gen Injections Feature Technology & Reconstitution April 30, 2024
Contributor Cindy H. Dubin highlights innovations from key players in parenteral delivery and prefilled syringes, with focuses on safety, meeting regulatory requirements, cost, fill/finish, and dosing.
FORMULATION FORUM - Prefilled Syringes: Overcoming the Challenges for Safe & Accurate Delivery of Drugs April 30, 2024
Shaukat Ali, PhD, and Jim Huang, PhD, provide a better understanding about some of the advantages of prefilled syringes, methods for manufacturing, and the syringe types commercially available.
Bespak Confirms Inhaled & Nasal Drug Delivery Business Separation From Recipharm April 2, 2024
Spin-out unites three sites to create a leading global CDMO as further significant investments announced at Holmes Chapel site….
SPECIAL FEATURE - Excipients: Advanced Biologics Require Innovative Excipient Science March 29, 2024
Contributor Cindy H. Dubin speaks with several leading companies to discuss novel and functional excipients being developed, the role they will play in reformulations and new formulations, and their versatility in drug delivery.
Evonik Partners With University of Mainz to Commercialize New Class of PEG Lipids for Nucleic Acid Delivery February 20, 2024
Evonik and the University of Mainz have signed a license agreement to commercialize randomized polyethylene glycols (rPEGs), a new class of PEGs. Evonik intends to use….
DRUG-DEVICE DEVELOPMENT - Exploring the Complexities of Drug-Device Combination Products
Jeremy Guo, Senior Vice President at WuXi Biologics, and colleagues explain that many factors need to be taken into account when producing a Drug-Device Combination Product from development testing to fill/finish and assembly.
CPHI Annual Report 2024: Drug Delivery Trends & Insights From a Device Perspective
Significant growth in the drug delivery sector is predicted for many areas, with headliners including cell and gene therapies and the GLP-1 blockbusters. Small molecule-based formulations still dominate innovator pipelines, but advanced biologics are also….
